TABLE 1. Human immunodeficiency virus (HIV) tests, new diagnoses, and previous diagnoses, by demographic characteristics and subpopulations — CDC-funded Phase-I Ending the HIV Epidemic (EHE) jurisdictions* and other CDC-funded testing sites, United States, 2017.
| Characteristic | Valid CDC-funded HIV tests |
New HIV diagnoses |
Previous HIV diagnoses not known to be in care |
||||
|---|---|---|---|---|---|---|---|
| CDC-funded tests |
CDC-funded tests, EHE jurisdictions |
New diagnoses |
New diagnoses, EHE jurisdictions |
New HIV positivity, EHE jurisdictions |
Previous diagnoses |
Previous diagnoses, EHE jurisdictions |
|
| No. | No. (Col %) | No. | No. (Col %) | (%) | No. | No. (Col %) | |
|
Age group (yrs)†
| |||||||
| 13–19 |
218,293 |
123,447 (6.3) |
434 |
279 (3.4) |
0.2 |
180 |
142 (1.6) |
| 20–29 |
1,175,736 |
704,303 (36.0) |
5,221 |
3,494 (42.9) |
0.5 |
3,345 |
2,696 (30.2) |
| 30–39 |
762,944 |
479,073 (24.5) |
3,249 |
2,322 (28.5) |
0.5 |
3,204 |
2,467 (27.7) |
| 40–49 |
416,566 |
276,244 (14.1) |
1,484 |
1,033 (12.7) |
0.4 |
2,134 |
1,674 (18.8) |
| ≥50 |
501,096 |
355,855 (18.2) |
1,411 |
993 (12.2) |
0.3 |
2,550 |
1,926 (21.6) |
|
Gender§
| |||||||
| Male |
1,575,493 |
1,021,993 (52.3) |
9,897 |
6,801 (83.4) |
0.7 |
8,898 |
6,967 (78.1) |
| Female |
1,498,393 |
906,192 (46.4) |
1,701 |
1,168 (14.3) |
0.1 |
2,288 |
1,744 (19.6) |
|
Test setting
| |||||||
| Health care facility |
2,388,928 |
1,502,673 (76.9) |
7,280 |
4,863 (59.6) |
0.3 |
8,352 |
6,754 (75.7) |
| Non–health care facility |
712,278 |
451,247 (23.1) |
4,539 |
3,290 (40.3) |
0.7 |
3,05 |
2,159 (24.2) |
|
U.S. Census region¶
| |||||||
| Northeast |
471,609 |
266,101 (13.6) |
1,707 |
1,216 (14.9) |
0.5 |
1,421 |
1,015 (11.4) |
| Midwest |
397,121 |
261,005 (13.4) |
1,661 |
1,136 (13.9) |
0.4 |
1,765 |
1,589 (17.8) |
| South |
1,792,105 |
1,114,464 (57.0) |
6,108 |
4,007 (49.1) |
0.4 |
7,283 |
5,530 (62.0) |
| West |
416,921 |
303,177 (15.5) |
2,144 |
1,691 (20.7) |
0.6 |
827 |
722 (8.1) |
| U.S. dependent areas |
32,293 |
9,994 (0.5) |
223 |
104 (1.3) |
1.0 |
131 |
61 (0.7) |
|
Race/Ethnicity**
| |||||||
| White |
819,524 |
421,656 (21.6) |
2,330 |
1,378 (16.9) |
0.3 |
2,104 |
1,516 (17.0) |
| Black or African American |
1,257,198 |
844,819 (43.2) |
5,622 |
4,007 (49.1) |
0.5 |
6,403 |
5,214 (58.5) |
| Hispanic or Latino |
677,954 |
437,635 (22.4) |
2,974 |
2,076 (25.5) |
0.5 |
1,913 |
1,359 (15.2) |
| Asian |
73,379 |
53,066 (2.7) |
223 |
164 (2.0) |
0.3 |
133 |
112 (1.3) |
| AI/AN |
16,269 |
7,519 (0.4) |
59 |
27 (0.3) |
0.4 |
39 |
24 (0.3) |
| H/PI |
6,509 |
4,176 (0.2) |
15 |
13 (0.2) |
0.3 |
14 |
12 (0.1) |
| Multirace |
23,935 |
12,497 (0.6) |
134 |
90 (1.1) |
0.7 |
76 |
51 (0.6) |
|
Subpopulation in non–health care setting††
| |||||||
| MSM |
180,748 |
123,635 (27.4) |
3,175 |
2,326 (70.7) |
1.9 |
1,602 |
1,204 (55.8) |
| Transgender persons |
7,763 |
5,377 (1.2) |
109 |
89 (2.7) |
1.7 |
70 |
55 (2.5) |
| Persons who inject drugs |
38,190 |
17,142 (3.8) |
145 |
98 (3.0) |
0.6 |
121 |
68 (3.1) |
| Heterosexual men |
173,259 |
100,521 (22.3) |
443 |
305 (9.3) |
0.3 |
424 |
265 (12.3) |
| Heterosexual women |
182,852 |
108,053 (23.9) |
376 |
262 (8.0) |
0.2 |
350 |
248 (11.5) |
| Total | 3,110,049 | 1,954,741 (100.0) | 11,843 | 8,154 (100.0) | 0.4 | 11,427 | 8,917 (100.0) |
Abbreviations: AI/AN = American Indian or Alaska Native; Col = column; H/PI = Native Hawaiian or Pacific Islander; MSM = gay, bisexual, and other men who have sex with men.
* Fifty local jurisdictions accounting for >50% of new diagnoses during 2016–2017 and seven states with disproportionate occurrence of HIV in rural areas.
† For age, the numbers of records missing or invalid are as follows: in the columns “Valid CDC-funded HIV tests,” 35,414 (1.1%) of all CDC-funded valid HIV tests and 15,819 (0.8%) of valid HIV tests in EHE jurisdictions; in the columns under “New HIV diagnoses,” 44 (0.4%) of total new diagnoses and 33 (0.4%) of new diagnoses in EHE jurisdictions; in the columns under “Previous HIV diagnoses,” 14 (0.1%) of total previous diagnoses and 12 (0.1%) of previous diagnoses in EHE jurisdictions.
§ For gender, the numbers of records reported as transgender, missing, or invalid are as follows: in the columns under “Valid CDC-funded HIV tests,” 36,163 (1.2%) of all CDC-funded valid HIV tests and 26,556 (1.4%) of valid HIV tests in EHE jurisdictions; in the columns under “New HIV diagnoses,” 245 (2.1%) of total new diagnoses and 185 (2.3%) of new diagnoses in EHE jurisdictions; in the columns under “Previous HIV diagnoses,” 241 (2.1%) of total previous diagnoses and 206 (2.3%) of previous diagnoses in EHE jurisdictions.
¶ Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont; Midwest: Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin; South: Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia; West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
** For race/ethnicity, the numbers of records missing or invalid are as follows: in the columns under “Valid CDC-funded HIV tests,” 235,281 (7.6%) of all CDC-funded valid HIV tests and 173,373 (8.9%) of valid HIV tests in EHE jurisdictions; in the columns under “New HIV diagnoses,” 486 (4.1%) of total new diagnoses and 399 (4.9%) of new diagnoses in EHE jurisdictions; in the columns under “Previous HIV diagnoses,” 745 (6.5%) of total previous diagnoses and 629 (7.1%) of previous diagnoses in EHE jurisdictions.
†† MSM include males who reported male-to-male sexual contact as well as males who reported both male-to-male sexual contact and injection drug use in the past 12 months. Persons who inject drugs include persons who reported injection drug use in the past 12 months. Heterosexual males include males who only reported sexual contact with a female in the past 12 months. Heterosexual females include females who only reported sexual contact with a male in the past 12 months. Data on subpopulations were limited to those tested in non–health care settings. For subpopulation in non–health care settings, the numbers of records missing or invalid are as follows: in the columns under “Valid CDC-funded HIV tests,” 129,466 (18.2%) of all CDC-funded valid HIV tests and 96,519 (21.4%) of valid HIV tests in EHE jurisdictions; in the columns under “New HIV diagnoses,” 291 (6.4%) of total new diagnoses and 210 (6.4%) of new diagnoses in EHE jurisdictions; in the columns under “Previous HIV diagnoses,” 483 (15.8%) of total previous diagnoses and 319 (14.8%) of previous diagnoses in EHE jurisdictions. Totals for subpopulation in non–health care settings are 712,278 for all CDC-funded HIV tests, 451,247 for CDC-funded tests in EHE jurisdictions, 4,539 for total new HIV diagnoses, 3,290 for new diagnoses in EHE jurisdictions, 3,050 for previously diagnosed, and 2,159 for previously diagnosed in EHE jurisdictions.